home

Bioclinica and ArisGlobal Partner to Transform Pharmacovigilance Model

EVENTSyahoo2016-04-20 09:38 Read   67

Bioclinica®, Inc., a specialty clinical trials technology and services provider, today announced the selection of ArisGlobal's Safety Cloud as the preferred safety platform for its pharmacovigilance services.

SANOFI INVESTS €300 MILLION TO EXPAND BIOLOGICS SITE IN BELGIUM

EVENTSsanofi2016-04-20 09:29 Read   69

Sanofi Invests €300 Million To Expand Biologics Site in Belgium;Additions to existing site will support production of monoclonal antibodies

DalCor Pharmaceuticals Completes $150 Million Financing

EVENTSprnewswire2016-04-20 09:21 Read   66

Proceeds to Fund Phase 3 Trial of Dalcetrapib in Genetically Distinct Patients with Acute Coronary Syndrome (ACS)

Bavarian Nordic A/S Completes a Private Placement at Market Price

EVENTSglobenewswire2016-04-20 09:11 Read   75

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION IN WHOLE OR IN PART IN OR INTO THE UNITED STATES, CANADA, AUSTRALIA, SOUTH AFRICA OR JAPAN.

BMA highlights concerns over NHS private providers

EVENTSpharmatimes2016-04-19 17:23 Read   71

More than two-thirds of doctors are uncomfortable with the use of private providers for NHS services, according to a new report by the British Medical Association.

Helminths, parasites and flukes, oh my! A review of treatments for common NTDs

Commentshealio2016-04-19 17:18 Read   75

Neglected tropical diseases, or NTDs, are a group of chronic, debilitating, communicable diseases that predominantly affect those living in poverty in developing countries in Latin America, Africa and South Asia.

Interview – Despite the many unknowns Celgene banks on CAR-T take-off

EVENTSepvantage2016-04-19 17:13 Read   68

Celgene is one of only two major drug  companies to make a big commitment to CAR-T, and its executives speak bullishly of the space.

San Diego Venture Funding Drops in QI—But Here are Top 10 Deals

EVENTSxconomy2016-04-19 17:02 Read   69

The pace of venture capital funding slowed substantially in San Diego during the first quarter, with venture firms investing $253.5 million in 21 startups, according to data from the MoneyTree Report.

Chiasma Shares Crater as FDA Rejects Hormone Drug, Asks For More Data

Regulatorxconomy2016-04-19 16:52 Read   106

Chiasma was on the doorstep of possible of approval of its first drug, a potential treatment for a rare hormonal disorder called acromegaly.

Roche's first-quarter prescription drug sales climb 5 percent, lifted by cancer therapies

EVENTSfirstwordpharma2016-04-19 16:35 Read   98

Roche announced Tuesday that sales of prescription drugs in the first quarter rose 5 percent year-over-year to 9.8 billion Swiss francs ($10.2 billion), boosted by revenue from cancer drugs and immunology therapies.

Merck Receives Breakthrough Therapy Designation from U.S. Food and Drug Administration for KEYTRUDA® (pembrolizumab) in Classical Hodgkin Lymphoma (cHL)

TrendMerck2016-04-19 16:22 Read   285

Fourth Designation for KEYTRUDA Follows Breakthrough Status in Advanced Melanoma, Non-Small Cell Lung Cancer, and Colorectal Cancer

UPDATED: J&J's Invokana under scrutiny in EU for potential link to toe amputations

EVENTSfiercepharma2016-04-19 13:31 Read   83

Johnson & Johnson’s ($JNJ) hot-selling Invokana has already come under scrutiny in the U.S. for safety issues, and now, it’s facing a new review across the pond. European regulators are sifting through data from a large ongoing clinical trial that showed an increase in toe amputations for patients taking the drug.